Medium spiny neurons (MSNs) are the principal neurons of the striatum, comprising approximately 95% of striatal neurons. These GABAergic projection neurons are critical for motor initiation, reward processing, and habit formation. In bipolar disorder, MSNs exhibit dysregulated dopamine signaling and altered firing patterns that contribute to mood instability, psychomotor disturbances, and emotional dysregulation characteristic of both manic and depressive phases. [1]
| Property | Value | [2]
|----------|-------| [3]
| Category | Basal Ganglia | [4]
| Location | Striatum (caudate nucleus, putamen), nucleus accumbens | [5]
| Cell Type | GABAergic medium spiny neurons | [6]
| Neurotransmitter | GABA (projecting), Dopamine (modulating) |
| Key Markers | DARPP-32, Drd1a, Drd2, Enkephalin, Substance P |
| Taxonomy | ID | Name / Label |
|---|---|---|
| Cell Ontology (CL) | CL:0000103 | bipolar neuron |
MSNs are divided into two anatomically and functionally distinct populations based on their dopamine receptor expression:
Direct Pathway MSNs (D1-MSNs): Express D1 dopamine receptors (Drd1a), substance P, and dynorphin. Project directly to the internal segment of the globus pallidus (GPi) and substantia nigra pars reticulata (SNr). Activation promotes motor initiation and reward.
Indirect Pathway MSNs (D2-MSNs): Express D2 dopamine receptors, enkephalin, and adenosine A2A receptors. Project to the external globus pallidus (GPe). Activation suppresses motor activity and inhibits reward processing.
| Finding | Mania | Depression |
|---|---|---|
| Dopamine | ↑ | ↓ |
| GABA | ↓ | Variable |
| Glutamate | ↑ | ↓ |
| Serotonin | ↓ | ↓ |
While bipolar disorder is primarily a psychiatric condition, emerging evidence suggests neurodegenerative components:
The study of Medium Spiny Neurons In Bipolar Disorder has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Marchand et al. Striatal signaling networks in bipolar disorder (2022). 2022. ↩︎
Sullivan et al. Dopamine and bipolar disorder (2021). 2021. ↩︎
Berk et al. Mood stabilizers and neuroprotection (2020). 2020. ↩︎
Calabrese et al. Striatal dysfunction in bipolar disorder (2019). 2019. ↩︎
Phillips & Swann, The dorsal striatum in bipolar disorder (2021). 2021. ↩︎
Nasrallah et al. Medium spiny neuron physiology in mood disorders (2022). 2022. ↩︎